4D Molecular Therapeutics

4D Molecular Therapeutics

4D Molecular Therapeutics

4D Molecular Therapeutics’ mission is to design and develop transformative genetherapy products using our proprietary.
Founded
2013
Raised
$93M
Follow us
Alexa global traffic share
Latest funding
$90,000,000
Venture capital (Series B) - 2018
Viking Global Investors
$3,000,000
Venture capital - 2017
Cystic Fibrosis Foundation
Team Size
10+
Employees
$90,000,000 Venture capital (Series B)
FinSMEs , PE HUB

4D Molecular Therapeutics Raises $90M in Series B Financing

Funding Health Science
MedCity News

MedImmune, 4D Molecular Therapeutics to collaborate on gene therapy